ICPerMed published Strategic Research and Innovation Agenda for Personalised Medicine
ICPerMed announced the publication of the Strategic Research and Innovation Agenda (SRIA) for Personalised Medicine (PM). This SRIA aims to support a wide range of stakeholders and experts to further develop programs, activities, and research towards PM and care, as well as prevention. In line with this mission, its main intention is to support the planned new European Partnership for Personalised Medicine (EP PerMed)
The goal is to ensure that the long-term vision of EP PerMed is translated into tailored roadmaps with funding and supporting activities, objectives, and measurable outcomes. Therewith, the SRIA complements the EP PerMed proposal that has recently been submitted to the European Commission (EC).
The SRIA was developed by a dedicated drafting group, composed of Member States representatives and in close collaboration with the EC. The structure and content of the SRIA is based on the drafting group members’ knowledge, existing strategic documents, and further available information. Even more importantly, it presents the outcome of several activities and events of which some were organised with the support of the EC, the International Consortium for Personalised Medicine (ICPerMed), and connected consortia like the European Research Area Network for Personalised Medicine (ERA PerMed).
Read the Strategic Research and Innovation Agenda here.